drugset / Trial / NCT01763996

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina

NCT01763996

Phase 4 Completed 30 enrolled Takeda
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the effect of febuxostat on coronary artery flow in patients with coronary artery disease.

Timeline

Start
2013-05
Primary completion
2015-03
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Febuxostat Small molecule 80 mg Oral